EKF Diagnostics to exhibit Maternal and Women's Health products at XXI FIGO World Congress

EKF Diagnostics, the global in vitro diagnostics company, announces that it is exhibiting its range of Maternal and Women's Health products at the XXI FIGO World Congress - the International Federation of Gynecology and Obstetrics - in Vancouver, Canada, 4-9^th October. EKF’s portfolio in this sector has been tailor made to address the specific healthcare needs women face during pregnancy and in their everyday lives.

The Creamatocrit™ Plus system helps ensure premature infants receive the calories they need. Image credit: EKF Diagnostics

At Booth #919, EKF is highlighting its Creamatocrit Plus™ mother’s milk fat and calories analyzer. This novel centrifuge with built-in tube reader is the first and only system dedicated to providing a fast and accurate creamatocrit measure of mother’s milk and estimate of calories. Small and lightweight with whisper quiet 3-minute operation, Creamatocrit Plus™ is particularly useful in neonatal intensive care units (NICU) to ensure that premature infants are receiving the calories that they need to thrive.

Creamatocrit Plus™ guides the separation of foremilk and the high lipid, high caloric hindmilk to accelerate weight gain in extremely low birthweight infants. To achieve this it uses a very simple, inexpensive and accurate technique for estimating the lipid concentration and calorific density in mothers’ milk.

Other EKF products being exhibited on Booth #919 at FIGO include its CLIA waived point-of-care pregnancy tests, Diaspect Tm hemoglobin analyzer and Lactate Scout+ lactate analyzer.

Pre-natal lactate testing seminar

Notably, EKF will also host a workshop entitled ‘Lactate in the peripartum period’ where eminent obstetricians will present on this key measure of fetal well-being. Professor Gian Carlo Di Renzo, FIGO Honorary Secretary, Perugia University, Italy, will provide an overview on ‘Lactate in Obstetrics’. Professor Wolfgang Henrich and Dr Johanna Stuckenschneider, Obstetrics and Gynecology Hospital Charite-Berlin, Germany, will discuss ‘Dystocia management and the impact of using a lactate point-of-care device.’ The workshop will be held on Wednesday 7^th October, 12.00-1.30pm, in Room 101-102, Level 1, West Building Convention Centre.

The FIGO World Congress of Gynecology and Obstetrics is a key conference in this field as it uniquely brings together professional societies of obstetricians and gynecologists on a global basis. It is one of the largest international gatherings of obstetricians, gynecologists, midwives, nurses, general practitioners and other specialists working in the field of women’s health. With member societies in 125 countries or territories, over 7,000 delegates from around the world are expected to attend.